APPH fundamentals
An in-depth look to APONTIS PHARM. AG INH ON operating, investing, and financing activities
APPH free cash flow for H2 24 is 899.64 k EUR. For 2024, APPH free cash flow was -2.98 M EUR and operating cash flow was -2.96 M EUR.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM